Literature DB >> 17371607

Medical therapies for chronic menorrhagia.

Anita L Nelson1, Stephanie B Teal.   

Abstract

An estimated 10%-30% of menstruating women experience menorrhagia at some time during their reproductive lives. Acute menorrhagia may present as an emergency requiring prompt medical or surgical intervention. Chronic menorrhagia affects a woman's quality of life in her work, family, and social interactions. Medical management is the first line of therapy for chronic menorrhagia. Agents that have been used to treat menorrhagia include iron, cyclooxygenase inhibitors, desmopressin, antifibrinolytics, gonadotropin-releasing hormone agonists, androgens, combined oral contraceptives, and progestins. Progestins can be administered systemically or locally and may be given cyclically or continuously. Increased use of effective medical therapies has the potential to reduce the number of surgical procedures, such as endometrial ablation and hysterectomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371607     DOI: 10.1097/01.ogx.0000259228.70277.6f

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  2 in total

Review 1.  Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors:  Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-02-09       Impact factor: 7.616

2.  The role of sevista in the management of dysfunctional uterine bleeding.

Authors:  Dhananjay Bs; Sunil Kumar Nanda
Journal:  J Clin Diagn Res       Date:  2012-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.